Prevalence of Pertactin-Deficient Bordetella pertussis Isolates, Slovenia - UTU Tutkimustietojärjestelmä

A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä

Prevalence of Pertactin-Deficient Bordetella pertussis Isolates, Slovenia

Tekijät: Barkoff, Alex-Mikael; Kastrin, Tamara; Seme, Katja; Vitek, Marta Grgič; Mertsola, Jussi; He, Qiushui

Kustantaja: Centers for Disease Control and Prevention (CDC)

Julkaisuvuosi: 2024

Journal: Emerging Infectious Diseases

Tietokannassa oleva lehden nimi: Emerging Infectious Diseases

Vuosikerta: 30

Numero: 11

ISSN: 1080-6040

eISSN: 1080-6059

DOI: https://doi.org/10.3201/eid3011.231393

Verkko-osoite: http://doi.org/10.3201/eid3011.231393

Rinnakkaistallenteen osoite: https://research.utu.fi/converis/portal/detail/Publication/470941132

Tiivistelmä

In Slovenia, primary acellular pertussis vaccines (ACVs) containing pertactin (PRN) were mostly used during 1999-2016; ACVs without PRN were introduced in 2017. Among 123 Bordetella pertussis strains collected during 2002-2020, a total of 48 were PRN-deficient; 44 were collected after 2017. Changes to ACVs could increase PRN-deficient B. pertussis and infections.

Ladattava julkaisu

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.

23-1393.pdf

Julkaisussa olevat rahoitustiedot:
This study is partly supported by Tampere Tuberculosis Foundation (grant no. 26006205), Sigrid Juselius Foundation (grant no. 240045), and EUpertstrain project (project nos. 26004877 and 26004878).